Burning Rock Biotech Ltd
BNR23.390USD
+1.690+7.79%
收盤 12/22, 16:00（美東）報價延遲15分鐘
211.19M總市值
虧損本益比TTM
關於 Burning Rock Biotech Ltd 公司
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Burning Rock Biotech Ltd簡介
公司代碼BNR
公司名稱Burning Rock Biotech Ltd
上市日期Jun 12, 2020
CEOHan (Yusheng)
員工數量674
證券類型Depository Receipt
年結日Jun 12
公司地址No. 5 Xingdao Ring Road North
城市GUANGZHOU
上市交易所NASDAQ OMX - NASDAQ BASIC
國家China
郵編510005
電話
網址https://www.brbiotech.com/
公司代碼BNR
上市日期Jun 12, 2020
CEOHan (Yusheng)
Burning Rock Biotech Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Feng Deng
Mr. Feng Deng
Director
Director
--
--
Ms. Xiaozhi Hu
Ms. Xiaozhi Hu
Senior Director in Finance
Senior Director in Finance
--
--
Ms. Wendy Hayes, CPA
Ms. Wendy Hayes, CPA
Independent Director
Independent Director
--
--
Dr. Lisa (Licen) Xu
Dr. Lisa (Licen) Xu
Independent Director
Independent Director
--
--
Mr. Yusheng Han
Mr. Yusheng Han
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Dr. Zhihong (Joe) Zhang, Ph.D.
Dr. Zhihong (Joe) Zhang, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Gang Lu
Mr. Gang Lu
Director
Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Feng Deng
Mr. Feng Deng
Director
Director
--
--
Ms. Xiaozhi Hu
Ms. Xiaozhi Hu
Senior Director in Finance
Senior Director in Finance
--
--
Ms. Wendy Hayes, CPA
Ms. Wendy Hayes, CPA
Independent Director
Independent Director
--
--
Dr. Lisa (Licen) Xu
Dr. Lisa (Licen) Xu
Independent Director
Independent Director
--
--
Mr. Yusheng Han
Mr. Yusheng Han
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Dr. Zhihong (Joe) Zhang, Ph.D.
Dr. Zhihong (Joe) Zhang, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
收入明細
FY2019
FY2018
由於公司未披露，未能獲取相關數據
地區USD
名稱
營收
佔比
China (Mainland)
0.00
0.00%
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 3 小時前
更新時間: 3 小時前
持股股東
股東類型
持股股東
持股股東
佔比
Northern Light Venture Capital
11.68%
Kynam Capital Management LP
11.02%
Lyfe Capital
9.24%
CRCM L.P.
5.39%
China Merchants Bank Co Ltd
5.13%
其他
57.55%
持股股東
持股股東
佔比
Northern Light Venture Capital
11.68%
Kynam Capital Management LP
11.02%
Lyfe Capital
9.24%
CRCM L.P.
5.39%
China Merchants Bank Co Ltd
5.13%
其他
57.55%
股東類型
持股股東
佔比
Private Equity
20.91%
Hedge Fund
11.37%
Investment Advisor/Hedge Fund
6.30%
Bank and Trust
5.14%
Corporation
3.92%
Investment Advisor
0.73%
Research Firm
0.58%
其他
51.05%
機構持股
更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
39
3.80M
46.56%
--
2025Q3
49
4.65M
47.27%
-5.46K
2025Q2
58
4.65M
51.33%
-759.34K
2025Q1
65
5.41M
53.38%
+589.94K
2024Q4
74
5.54M
50.70%
+348.38K
2024Q3
93
5.26M
57.60%
-7.02K
2024Q2
108
5.27M
61.36%
-5.69K
2024Q1
121
5.30M
64.27%
-181.25K
2023Q4
137
5.23M
65.24%
+745.66K
2023Q3
205
5.00M
74.63%
-61.48K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Northern Light Venture Capital
1.05M
11.68%
--
--
Mar 31, 2025
Kynam Capital Management LP
994.88K
11.02%
--
--
Jun 30, 2025
Lyfe Capital
833.84K
9.24%
--
--
Mar 31, 2025
CRCM L.P.
194.77K
2.16%
-31.52K
-13.93%
Jun 30, 2025
China Merchants Bank Co Ltd
462.99K
5.13%
--
--
Mar 31, 2025
Quantum Boundary Holdings Ltd
353.92K
3.92%
+350.62K
+10637.83%
Mar 31, 2025
Amova Asset Management Americas, Inc
45.55K
0.5%
+45.55K
--
Dec 31, 2024
Amova Asset Management Co., Ltd.
43.93K
0.49%
--
--
Jun 30, 2025
Renaissance Technologies LLC
31.72K
0.35%
--
--
Jun 30, 2025
BofA Global Research (US)
29.28K
0.32%
-18.00
-0.06%
Jun 30, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Avantis Responsible Emerging Markets Equity ETF
0%
DFA Dimensional Emerging Markets Core Equity 2 ETF
0%
SPDR S&P Emerging Markets Small Cap ETF
0%
Avantis Responsible Emerging Markets Equity ETF
佔比0%
DFA Dimensional Emerging Markets Core Equity 2 ETF
佔比0%
SPDR S&P Emerging Markets Small Cap ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
公告日期
類型
比率
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
常見問題
Burning Rock Biotech Ltd的前五大股東是誰？
Burning Rock Biotech Ltd的前五大股東如下：
Northern Light Venture Capital持有股份：1.05M佔總股份比例：11.68%。
Kynam Capital Management LP持有股份：994.88K佔總股份比例：11.02%。
Lyfe Capital持有股份：833.84K佔總股份比例：9.24%。
CRCM L.P.持有股份：194.77K佔總股份比例：2.16%。
China Merchants Bank Co Ltd持有股份：462.99K佔總股份比例：5.13%。
Northern Light Venture Capital持有股份：1.05M佔總股份比例：11.68%。
Kynam Capital Management LP持有股份：994.88K佔總股份比例：11.02%。
Lyfe Capital持有股份：833.84K佔總股份比例：9.24%。
CRCM L.P.持有股份：194.77K佔總股份比例：2.16%。
China Merchants Bank Co Ltd持有股份：462.99K佔總股份比例：5.13%。
Burning Rock Biotech Ltd的前三大股東類型是什麼？
Burning Rock Biotech Ltd 的前三大股東類型分別是：
Northern Light Venture Capital
Kynam Capital Management LP
Lyfe Capital
Northern Light Venture Capital
Kynam Capital Management LP
Lyfe Capital
有多少機構持有Burning Rock Biotech Ltd(BNR)的股份？
截至2025Q4，共有39家機構持有Burning Rock Biotech Ltd的股份，合計持有的股份價值約為3.80M，占公司總股份的46.56% 。與2025Q3相比，機構持股有所增加，增幅為-0.72%。
哪個業務部門對Burning Rock Biotech Ltd的收入貢獻最大？
在FY2019，--業務部門對Burning Rock Biotech Ltd的收入貢獻最大，創收--，占總收入的--% 。
